5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dornase alfa for cystic fibrosis

      1 , 2
      Cochrane Cystic Fibrosis and Genetic Disorders Group
      Cochrane Database of Systematic Reviews
      Wiley

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previously published review.

          Related collections

          Author and article information

          Journal
          146518
          Cochrane Database of Systematic Reviews
          Wiley
          14651858
          September 06 2018
          Affiliations
          [1 ]BC Children's Hospital; Department of Pediatrics, Division of Respiratory Medicine; 4480 Oak Street Vancouver BC Canada V6H 3V4
          [2 ]Alberta Children's Hospital; Pediatrics and Child Health; 2888 Shaganappi Trail NW Calgary AB Canada T3B 6A8
          Article
          10.1002/14651858.CD001127.pub4
          6513278
          30187450
          daf2407d-dbc0-43f7-bff6-fb513cf5a59e
          © 2018
          History

          Comments

          Comment on this article